Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ)

CNY 14.75

(0.07%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 3.93 Billion 3.96 Billion 4.09 Billion 3.88 Billion 3.41 Billion 3.4 Billion
Total Current Assets 2.19 Billion 2.29 Billion 2.45 Billion 2.37 Billion 1.98 Billion 2.12 Billion
Cash And Short Term Investments 1.36 Billion 1.42 Billion 1.69 Billion 1.71 Billion 1.23 Billion 1.21 Billion
Cash and Cash Equivalents 1.05 Billion 1.26 Billion 1.47 Billion 1.36 Billion 1.16 Billion 1.21 Billion
Short Term Investments 304.69 Million 161.23 Million 221.76 Million 355.33 Million 67.5 Million 1271.23
Net Receivables 515.31 Million 621.05 Million 447.07 Million 428.58 Million 545.41 Million 659.89 Million
Inventory 255.95 Million 244.89 Million 284.15 Million 194.37 Million 176.33 Million 148.43 Million
Other Current Assets 61.97 Million 4.09 Million 23.45 Million 39.69 Million 29.25 Million 100.99 Million
Total Non-Current Assets 1.73 Billion 1.66 Billion 1.64 Billion 1.5 Billion 1.42 Billion 1.27 Billion
Net PPE 1.15 Billion 1.22 Billion 1.31 Billion 1.3 Billion 1.22 Billion 1.05 Billion
Good Will And Intangible Assets 159.25 Million 173.97 Million 184.06 Million 180.24 Million 179.92 Million 181.91 Million
Good Will 5.69 Million 5.69 Million 5.69 Million 5.69 Million 5.69 Million 5.69 Million
Intangible Assets 153.55 Million 168.27 Million 178.36 Million 174.55 Million 174.22 Million 176.21 Million
Long-Term Investments -207 Million -28.62 Million -217.55 Million -351.13 Million -60.44 Million 28.09 Million
Tax Assets 9.33 Million 8.52 Million 11.35 Million 8.82 Million 9.9 Million 13.79 Million
Other Non Current Assets 623.13 Million 286.99 Million 350.6 Million 364.17 Million 75.74 Million 3.2 Million
Other Assets 1.00 1.00 - - 1.00 1.00
Total Liabilities 1.11 Billion 1.15 Billion 1.25 Billion 923.27 Million 600.18 Million 599.46 Million
Total Current Liabilities 893.83 Million 846.93 Million 829.22 Million 589.31 Million 405.26 Million 484.98 Million
Account Payables 201.37 Million 133.91 Million 180.24 Million 91.56 Million 125.17 Million 162.62 Million
Tax Payables 46.34 Million 93.15 Million 47.26 Million 32.66 Million 44.12 Million 91.51 Million
Short Term Debt 393.45 Million 259.39 Million 294.23 Million 166.19 Million 109.38 Million 100 Million
Deferred Revenue 289.42 Million 170 Million 337.94 Million 311.2 Million 146.22 Million 91.51 Million
Other Current Liabilities 9.57 Million 283.61 Million 16.8 Million 20.35 Million 24.49 Million 130.84 Million
Total Non Current Liabilities 225.25 Million 304.65 Million 426.82 Million 333.95 Million 194.91 Million 114.47 Million
Long-Term Debt 134.87 Million 206.48 Million 314.86 Million 233.34 Million 74.84 Million -
Deferred Revenue Non Current 89.04 Million 97.84 Million 111.22 Million 94.89 Million 105.12 Million 114.47 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.33 Million 1.00 1.00 5.13 Million 74.84 Million 0.32
Other Liabilities 1.00 - 1.00 - - -
Total Equity 2.81 Billion 2.81 Billion 2.83 Billion 2.95 Billion 2.81 Billion 2.8 Billion
Stock Holders Equity 2.81 Billion 2.81 Billion 2.83 Billion 2.95 Billion 2.81 Billion 2.8 Billion
Common Stock 587.56 Million 587.56 Million 590.2 Million 590.2 Million 590.2 Million 590.2 Million
Retained Earnings 1.25 Billion 1.24 Billion 1.44 Billion 1.55 Billion 1.41 Billion 1.22 Billion
Accumulated other comprehensive income 2.97 Billion 409.87 Million 326.13 Million 328.82 Million 329.96 Million 329.96 Million
Common Stock Equity 2.81 Billion 2.81 Billion 2.83 Billion 2.95 Billion 2.81 Billion 2.8 Billion
Capital Lease Obligation 60.95 Million 78.45 Million 87.93 Million 107.66 Million 14.94 Million -
Total Investments 97.68 Million 132.61 Million 4.2 Million 4.2 Million 7.05 Million 28.09 Million
Total Debt 528.33 Million 465.87 Million 609.09 Million 399.54 Million 184.22 Million 100 Million
Net Debt -529.77 Million -799.83 Million -868.57 Million -962.36 Million -984.33 Million -1.11 Billion

Balance Sheet Charts